Therachon

Therachon

Therachon

We are focused on developing treatments for rare, genetic diseases. Our lead pipeline candidate is in development for achondroplasia or short-limbed dwarfism.
Raised
$60M
Follow us
Alexa global traffic share
Twitter followers
09 Aug 2018
$60,000,000
Venture capital (Series B)